FDA Looks to Ease Stakeholder Confusion Over UDI Direct Marking Requirements

The GMP Letter
The FDA is clarifying language related to the direct marking of medical devices for unique device identification purposes, including the definition of reprocessing.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00